Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267267
Status:
TERMINATED
Last Update Posted:
2007-12-10
First Post:
2005-12-19
Brief Title:
A Clinical Trial Comparing TorcetrapibAtorvastatin to EzetimibeSimvastatin In Subjects With A Cholesterol Disorder
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Phase 3 Open-Label Multi-Center Double-Blind Randomized Parallel Group Study Efficacy and Safety of Fixed Combination TorcetrapibAtorvastatin Administered Once Daily QD Compared to Fixed Combination EzetimibeSimvastatin for 6 Weeks in Subjects With Dyslipidemia
Status:
TERMINATED
Status Verified Date:
2006-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Torcetrapib project was terminated on December 2 2006 due to safety findings
Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of combination cholesterol medications to see how the different treatments compare to one another
Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of combination cholesterol medications to see how the different treatments compare to one another
Detailed Description:
For additional information please call 1-800-718-1021
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None